Two, characterizing serum and plasma markers (resorption CTX, formation P1NP, sclerostin, insulin, insulin-like growth factor 1, IL-6, TNFα, etc.)would identify potential metabolic pathways by which diet and diabetes lower the fracture resistance of bone. The gene discussed is IGF1; the disease is diabetes mellitus.